Oncology Drugs (Oral) Market Report

China Oncology Drugs (Oral) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 17, 2023
  • PAGES：144
  • REPORT CODE：GMM1804837
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Oncology Drugs (Oral) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Astellas Pharma Inc

    • Bristol-Myers Squibb Company

    • AbbVie Inc

    • Pfizer Inc

    • Johnson & Johnson

    • Amgen

    • Merck & Co, Inc

    • AstraZeneca PLC

    • F Hoffmann-La Roche Ltd

    By Type:

    • Esophagus Cancer

    • Stomach Cancer

    • Lung Cancer

    • Cervical Cancer

    • Bladder Cancer

    • Liver Cancer

    • Kidney Cancer

    • Other Cancers

    • Prostate Cancer

    • Colorectal Cancer

    • Breast Cancer

    By Application:

    • Retail Pharmacies/Drug Stores

    • Hospital Pharmacies

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Oncology Drugs (Oral) Market Overview 2018-2029

    • 1.1 China Oncology Drugs (Oral) Industry Development Overview

    • 1.2 China Oncology Drugs (Oral) Industry Development History

    • 1.3 China Oncology Drugs (Oral) Industry Market Size (2018-2029)

    • 1.4 China Oncology Drugs (Oral) Market Analysis by Type from Production Side

      • 1.4.1 China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Esophagus Cancer (2018-2029)

      • 1.4.2 China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Stomach Cancer (2018-2029)

      • 1.4.3 China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Lung Cancer (2018-2029)

      • 1.4.4 China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Cervical Cancer (2018-2029)

      • 1.4.5 China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Bladder Cancer (2018-2029)

      • 1.4.6 China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Liver Cancer (2018-2029)

      • 1.4.7 China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Kidney Cancer (2018-2029)

      • 1.4.8 China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Other Cancers (2018-2029)

      • 1.4.9 China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Prostate Cancer (2018-2029)

      • 1.4.10 China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Colorectal Cancer (2018-2029)

      • 1.4.11 China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Breast Cancer (2018-2029)

    • 1.5 China Oncology Drugs (Oral) Market Analysis by Application from Consumption End

      • 1.5.1 China Oncology Drugs (Oral) Sales Volume, Sales Value and Growth Rate of Retail Pharmacies/Drug Stores (2018-2029)

      • 1.5.2 China Oncology Drugs (Oral) Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

      • 1.5.3 China Oncology Drugs (Oral) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Oncology Drugs (Oral) Market Analysis by Region

      • 1.6.1 North China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Oncology Drugs (Oral) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Oncology Drugs (Oral) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Oncology Drugs (Oral) Market Status and Competition Analysis in 2023

      • 2.2.3 China Oncology Drugs (Oral) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Oncology Drugs (Oral) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Oncology Drugs (Oral) Industry Development

    Chapter 3 Oncology Drugs (Oral)Industry Chain Analysis

    • 3.1 Oncology Drugs (Oral) Industry Chain

    • 3.2 Oncology Drugs (Oral) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Oncology Drugs (Oral) Market

    • 3.3 Oncology Drugs (Oral) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Oncology Drugs (Oral) Market

    Chapter 4 China Oncology Drugs (Oral) Market, by Type

    • 4.1 China Oncology Drugs (Oral) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Oncology Drugs (Oral) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Oncology Drugs (Oral) Production Volume and Growth Rate, by Type

      • 4.5.1 China Oncology Drugs (Oral) Production Volume and Growth Rate of Esophagus Cancer

      • 4.5.2 China Oncology Drugs (Oral) Production Volume and Growth Rate of Stomach Cancer

      • 4.5.3 China Oncology Drugs (Oral) Production Volume and Growth Rate of Lung Cancer

      • 4.5.4 China Oncology Drugs (Oral) Production Volume and Growth Rate of Cervical Cancer

      • 4.5.5 China Oncology Drugs (Oral) Production Volume and Growth Rate of Bladder Cancer

      • 4.5.6 China Oncology Drugs (Oral) Production Volume and Growth Rate of Liver Cancer

      • 4.5.7 China Oncology Drugs (Oral) Production Volume and Growth Rate of Kidney Cancer

      • 4.5.8 China Oncology Drugs (Oral) Production Volume and Growth Rate of Other Cancers

      • 4.5.9 China Oncology Drugs (Oral) Production Volume and Growth Rate of Prostate Cancer

      • 4.5.10 China Oncology Drugs (Oral) Production Volume and Growth Rate of Colorectal Cancer

      • 4.5.11 China Oncology Drugs (Oral) Production Volume and Growth Rate of Breast Cancer

    Chapter 5 China Oncology Drugs (Oral) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Oncology Drugs (Oral) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Oncology Drugs (Oral) Market Size and Growth Rate, by Application

      • 5.5.1 China Oncology Drugs (Oral) Market Size and Growth Rate of Retail Pharmacies/Drug Stores

      • 5.5.2 China Oncology Drugs (Oral) Market Size and Growth Rate of Hospital Pharmacies

      • 5.5.3 China Oncology Drugs (Oral) Market Size and Growth Rate of Others

    Chapter 6 China Oncology Drugs (Oral) Market, by Region

    • 6.1 China Oncology Drugs (Oral) Production Volume and Production Value, by Region

    • 6.2 China Oncology Drugs (Oral) Sales Volume and Sales Value, by Region

    Chapter 7 North China Oncology Drugs (Oral) Market Analysis

    • 7.1 North China Oncology Drugs (Oral) Market, by Type

    • 7.2 North China Oncology Drugs (Oral) Market, by Application

    Chapter 8 Central China Oncology Drugs (Oral) Market Analysis

    • 8.1 Central China Oncology Drugs (Oral) Market, by Type

    • 8.2 Central China Oncology Drugs (Oral) Market, by Application

    Chapter 9 South China Oncology Drugs (Oral) Market Analysis

    • 9.1 South China Oncology Drugs (Oral) Market, by Type

    • 9.2 South China Oncology Drugs (Oral) Market, by Application

    Chapter 10 East China Oncology Drugs (Oral) Market Analysis

    • 10.1 East China Oncology Drugs (Oral) Market, by Type

    • 10.2 East China Oncology Drugs (Oral) Market, by Application

    Chapter 11 Northeast China Oncology Drugs (Oral) Market Analysis

    • 11.1 Northeast China Oncology Drugs (Oral) Market, by Type

    • 11.2 Northeast China Oncology Drugs (Oral) Market, by Application

    Chapter 12 Southwest China Oncology Drugs (Oral) Market Analysis

    • 12.1 Southwest China Oncology Drugs (Oral) Market, by Type

    • 12.2 Southwest China Oncology Drugs (Oral) Market, by Application

    Chapter 13 Northwest China Oncology Drugs (Oral) Market Analysis

    • 13.1 Northwest China Oncology Drugs (Oral) Market, by Type

    • 13.2 Northwest China Oncology Drugs (Oral) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Astellas Pharma Inc

        • 14.1.1 Astellas Pharma Inc Company Profile

        • 14.1.2 Astellas Pharma Inc Oncology Drugs (Oral) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bristol-Myers Squibb Company

        • 14.2.1 Bristol-Myers Squibb Company Company Profile

        • 14.2.2 Bristol-Myers Squibb Company Oncology Drugs (Oral) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 AbbVie Inc

        • 14.3.1 AbbVie Inc Company Profile

        • 14.3.2 AbbVie Inc Oncology Drugs (Oral) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Pfizer Inc

        • 14.4.1 Pfizer Inc Company Profile

        • 14.4.2 Pfizer Inc Oncology Drugs (Oral) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Johnson & Johnson

        • 14.5.1 Johnson & Johnson Company Profile

        • 14.5.2 Johnson & Johnson Oncology Drugs (Oral) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Amgen

        • 14.6.1 Amgen Company Profile

        • 14.6.2 Amgen Oncology Drugs (Oral) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Merck & Co, Inc

        • 14.7.1 Merck & Co, Inc Company Profile

        • 14.7.2 Merck & Co, Inc Oncology Drugs (Oral) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 AstraZeneca PLC

        • 14.8.1 AstraZeneca PLC Company Profile

        • 14.8.2 AstraZeneca PLC Oncology Drugs (Oral) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 F Hoffmann-La Roche Ltd

        • 14.9.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.9.2 F Hoffmann-La Roche Ltd Oncology Drugs (Oral) Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Oncology Drugs (Oral) Industry Research Conclusions

    • 15.2 Oncology Drugs (Oral) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Oncology Drugs (Oral) Industry Market Size (2018-2029)

    • Figure China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Esophagus Cancer (2018-2029)

    • Figure China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Stomach Cancer (2018-2029)

    • Figure China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Cervical Cancer (2018-2029)

    • Figure China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Bladder Cancer (2018-2029)

    • Figure China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Liver Cancer (2018-2029)

    • Figure China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Kidney Cancer (2018-2029)

    • Figure China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Other Cancers (2018-2029)

    • Figure China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Prostate Cancer (2018-2029)

    • Figure China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Colorectal Cancer (2018-2029)

    • Figure China Oncology Drugs (Oral) Production Volume, Production Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Oncology Drugs (Oral) Sales Volume, Sales Value and Growth Rate of Retail Pharmacies/Drug Stores (2018-2029)

    • Figure China Oncology Drugs (Oral) Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure China Oncology Drugs (Oral) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

    • Figure Central China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

    • Figure South China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

    • Figure East China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Oncology Drugs (Oral) Market Size and Growth Rate from 2018-2029

    • Figure Oncology Drugs (Oral) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Oncology Drugs (Oral) Market Share by Type in 2018

    • Figure China Oncology Drugs (Oral) Market Share by Type in 2023

    • Figure China Oncology Drugs (Oral) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume and Growth Rate of Esophagus Cancer (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume and Growth Rate of Stomach Cancer (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume and Growth Rate of Lung Cancer (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume and Growth Rate of Cervical Cancer (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume and Growth Rate of Bladder Cancer (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume and Growth Rate of Liver Cancer (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume and Growth Rate of Kidney Cancer (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume and Growth Rate of Other Cancers (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume and Growth Rate of Prostate Cancer (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume and Growth Rate of Colorectal Cancer (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Oncology Drugs (Oral) Market Share by Application in 2018

    • Figure China Oncology Drugs (Oral) Market Share by Application in 2023

    • Figure China Oncology Drugs (Oral) Total Market Size and Growth Rate from Consumption End

    • Figure China Oncology Drugs (Oral) Market Size and Growth Rate of Retail Pharmacies/Drug Stores (2018-2023)

    • Figure China Oncology Drugs (Oral) Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Figure China Oncology Drugs (Oral) Market Size and Growth Rate of Others (2018-2023)

    • Table China Oncology Drugs (Oral) Production Volume by Region (2018-2023)

    • Table China Oncology Drugs (Oral) Production Volume Share by Region (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Volume Share by Region (2018-2023)

    • Table China Oncology Drugs (Oral) Production Value by Region (2018-2023)

    • Table China Oncology Drugs (Oral) Production Value Share by Region (2018-2023)

    • Figure China Oncology Drugs (Oral) Production Value Share by Region (2018-2023)

    • Table China Oncology Drugs (Oral) Sales Volume by Region (2018-2023)

    • Table China Oncology Drugs (Oral) Sales Volume Share by Region (2018-2023)

    • Figure China Oncology Drugs (Oral) Sales Volume Share by Region (2018-2023)

    • Table China Oncology Drugs (Oral) Sales Value by Region (2018-2023)

    • Table China Oncology Drugs (Oral) Sales Value Share by Region (2018-2023)

    • Figure China Oncology Drugs (Oral) Sales Value Share by Region (2018-2023)

    • Table North China Oncology Drugs (Oral) Production Volume by Type (2018-2023)

    • Table North China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Figure North China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Table North China Oncology Drugs (Oral) Sales Volume by Application (2018-2023)

    • Table North China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Figure North China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Table Central China Oncology Drugs (Oral) Production Volume by Type (2018-2023)

    • Table Central China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Figure Central China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Table Central China Oncology Drugs (Oral) Sales Volume by Application (2018-2023)

    • Table Central China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Figure Central China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Table South China Oncology Drugs (Oral) Production Volume by Type (2018-2023)

    • Table South China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Figure South China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Table South China Oncology Drugs (Oral) Sales Volume by Application (2018-2023)

    • Table South China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Figure South China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Table East China Oncology Drugs (Oral) Production Volume by Type (2018-2023)

    • Table East China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Figure East China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Table East China Oncology Drugs (Oral) Sales Volume by Application (2018-2023)

    • Table East China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Figure East China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Oncology Drugs (Oral) Production Volume by Type (2018-2023)

    • Table Northeast China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Table Northeast China Oncology Drugs (Oral) Sales Volume by Application (2018-2023)

    • Table Northeast China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Oncology Drugs (Oral) Production Volume by Type (2018-2023)

    • Table Southwest China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Table Southwest China Oncology Drugs (Oral) Sales Volume by Application (2018-2023)

    • Table Southwest China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Oncology Drugs (Oral) Production Volume by Type (2018-2023)

    • Table Northwest China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Oncology Drugs (Oral) Production Volume Share by Type (2018-2023)

    • Table Northwest China Oncology Drugs (Oral) Sales Volume by Application (2018-2023)

    • Table Northwest China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Oncology Drugs (Oral) Sales Volume Share by Application (2018-2023)

    • Table Astellas Pharma Inc Company Profile

    • Table Astellas Pharma Inc Oncology Drugs (Oral) Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Oncology Drugs (Oral) Revenue, Price and Gross (2018-2023)

    • Table AbbVie Inc Company Profile

    • Table AbbVie Inc Oncology Drugs (Oral) Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Oncology Drugs (Oral) Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Oncology Drugs (Oral) Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Oncology Drugs (Oral) Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Oncology Drugs (Oral) Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca PLC Company Profile

    • Table AstraZeneca PLC Oncology Drugs (Oral) Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Oncology Drugs (Oral) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US